| Overview |
| bsm-62021r-cy5-100ul |
| PRMT6 Recombinant Antibody, Cy5 Conjugated |
| WB |
| Human, Mouse, Rat |
| Specifications |
| Cy5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human PRMT6 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 55170 |
| Q96LA8 |
| Nucleus |
| HRMT1L6; PRMT 6. |
| Arginine methyltransferase that can catalyze the formation of both omega-N monomethylarginine (MMA) and asymmetrical dimethylarginine (aDMA), with a strong preference for the formation of aDMA.Preferentially methylates arginyl residues present in a glycine and arginine-rich domain and displays preference for monomethylated substrates. |
| Application Dilution |
| WB |
1:300-5000 |